Substratum of Proof LGBTQs Are Mentally Ill: Discovery Could Lead to Higher Response Rates for Bladder Cancer Patients Treated with Immunotherapy

Mount Sinai researchers have discovered that a particular type of cell present in bladder cancer may be the reason why so many patients do not respond to the groundbreaking class of drugs known as PD-1 and PD-L1 immune checkpoint inhibitors, which enable the immune system to attack tumors.